Author details

Full Name

George P Christophi

Affiliation

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33068786	Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.	Clin Gastroenterol Hepatol	2021
34037225	Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases.	Inflammatory Bowel Diseases	2021
32629130	Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis.	Clin Gastroenterol Hepatol	2021
30753456	Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and Infliximab.	Inflammatory Bowel Diseases	2019
30295784	Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.	Inflamm Bowel Dis	2019
30810748	Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.	Inflamm Bowel Dis	2019
30333545	Mucinous Small Bowel Adenocarcinoma Mimicking Change to Internal Penetrating Phenotype in Well-controlled Crohn's Disease.	American Journal of Gastroenterology	2018
30122655	Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration.		2018
28617889	Erdheim-Chester Disease presenting with histiocytic colitis and cytokine storm.		2017
28774928	The microbial metabolite desaminotyrosine protects from influenza through type I interferon.	Science	2017
27274301	Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach.	Clinical and Experimental Gastroenterology	2016
26057322	Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?	Journal of Clinical Gastroenterology	2015
25919645	The control of reactive oxygen species production by SHP-1 in oligodendrocytes.	GLIA	2015
25153387	Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.	Biological Chemistry	2014
24768588	Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.	Experimental and Molecular Pathology	2014
22189043	Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients.	Clinical Immunology	2012
22467146	Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease.	Inflammatory Bowel Diseases	2012
21658727	Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-Î² 1a treated multiple sclerosis patients.	Journal of the Neurological Sciences	2011
18987138	Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.	Journal of Virology	2009
19398961	Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.	Laboratory Investigation	2009
19559654	Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.	Clinical Immunology	2009
19951174	Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.	Viral Immunology	2009
18209728	SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.	Laboratory Investigation	2008
18331586	Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia.	Journal of Neurochemistry	2008
18552204	Induction of IL-33 expression and activity in central nervous system glia.	Journal of Leukocyte Biology	2008
18250891	Regulation of avoidant behaviors and pain by the anti-inflammatory tyrosine phosphatase SHP-1.	Neuron Glia Biology	2006
16824622	Potential scope of action of tissue kallikreins in CNS immune-mediated disease.	Journal of Neuroimmunology	2006
15033932	Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease.	FASEB Journal	2004
15584920	Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease.	Journal of Neurochemistry	2004